Med-X, Inc. (MXRX)

Med-X Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2021	Dec 31, 2020
Net Income	-7.58	-4.91	-3.54
Depreciation & Amortization	0.04	0.05	0.11
Share-Based Compensation	-	1.01	0.36
Other Operating Activities	2.13	-0.57	-0.23
Operating Cash Flow	-5.4	-4.41	-3.3
Capital Expenditures	-0.09	-0.04	-0
Other Investing Activities	-	0.04	-
Investing Cash Flow	-0.09	-0	-0
Share Issuance / Repurchase	-	5.12	3.53
Debt Issued / Paid	-	-0.09	0.31
Financing Cash Flow	4.78	5.03	3.83
Net Cash Flow	-0.71	0.61	0.53
Free Cash Flow	-5.49	-4.45	-3.31
Free Cash Flow Margin	-392.10%	-440.57%	-319.75%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).